Company: BKR
Filing Date: 2025-03-25
Form Type: 8-K
Source: 0001701605-25-000068
Chunk: 0

Company: Baker Hughes Co
Filing Date: 2025-03-25
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01 Regulation FD.

In the first quarter of 2025, Baker Hughes Company ("the Company") intends to make the following changes to the presentation of its income statement in connection with its forthcoming Form 10-Q for the fiscal quarter ended March 31, 2025: (i) separately present research and development costs and to (ii) remove both the sub-total of operating income and the non-operating income (loss) line item. These presentation changes did not impact the historically reported consolidated or segment financial results in any period.

Under the new presentation, research and development costs and other (income) expense, net will be reported as separate financial statement line items, with related expense amounts being reclassified thereto, and the operating income and non-operating income (loss) line items will be removed from the consolidated statements of income (loss). The Company has prepared unaudited historical consolidated financial information ("Financial Supplement"), which has been retrospectively adjusted to reflect this voluntary change in presentation.

Such information is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. In accordance with General Instructions B.2. of Form 8-K, the information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under Securities Act of 1934, as amended, except as shall be expressly set forth by specific reference in such a filing.

The information in this Current Report on Form 8-K should be read in conjunction with Baker Hughes' Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2024, June 30, 2024 and September 30, 2024.

Item 9.01 Financial Statements and Exhibits.